ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 650,38
0,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Synlogic Com USD0.001 (MIRN)

  7. Synlogic Com USD0.001 (MIRN) Actualités

MIRN

MIRNA THERAPEUTICS, INC. (MIRN)

Synlogic Com USD0.001
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MIRN
DateHeureSourceTitreSymboleSociété
26/09/201722h07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MIRNSynlogic Com USD0.001
19/09/201718h06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MIRNSynlogic Com USD0.001
07/09/201720h21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MIRNSynlogic Com USD0.001
07/09/201720h10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MIRNSynlogic Com USD0.001
06/09/201712h04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MIRNSynlogic Com USD0.001
30/08/201722h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MIRNSynlogic Com USD0.001
30/08/201722h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIRNSynlogic Com USD0.001
28/08/201722h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MIRNSynlogic Com USD0.001
25/08/201714h15Business WireMirna Therapeutics Announces Results of Annual Meeting of StockholdersNASDAQ:MIRNSynlogic Com USD0.001
04/08/201712h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MIRNSynlogic Com USD0.001
14/07/201712h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MIRNSynlogic Com USD0.001
13/07/201722h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MIRNSynlogic Com USD0.001
11/07/201714h14Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MIRNSynlogic Com USD0.001
21/06/201723h13Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MIRNSynlogic Com USD0.001
09/06/201722h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MIRNSynlogic Com USD0.001
16/05/201712h30Business WireSynlogic and Mirna Therapeutics Agree to MergerNASDAQ:MIRNSynlogic Com USD0.001
09/05/201723h30Business WireMirna Therapeutics Reports First Quarter 2017 Financial ResultsNASDAQ:MIRNSynlogic Com USD0.001
15/03/201711h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MIRNSynlogic Com USD0.001
14/03/201723h11Business WireMirna Therapeutics Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016NASDAQ:MIRNSynlogic Com USD0.001
14/02/201717h42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MIRNSynlogic Com USD0.001
10/11/201622h59Business WireMirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
20/09/201622h05Business WireMirna Therapeutics Halts Phase 1 Clinical Study of MRX34NASDAQ:MIRNSynlogic Com USD0.001
31/08/201613h00Business WireMirna Therapeutics to Participate in Two Healthcare Investor Conferences in SeptemberNASDAQ:MIRNSynlogic Com USD0.001
15/08/201613h00Business WireMirna Therapeutics Reports Second Quarter 2016 Financial Results and Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
05/07/201613h00Business WireMirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare ConferenceNASDAQ:MIRNSynlogic Com USD0.001
30/06/201613h00Business WireMirna Therapeutics Appoints Perry Nisen, M.D., Ph.D., to Its Board of DirectorsNASDAQ:MIRNSynlogic Com USD0.001
06/06/201618h00Business WireMirna Therapeutics Announces Clinical Data on its Lead microRNA Therapeutic Presented at ASCONASDAQ:MIRNSynlogic Com USD0.001
12/05/201622h05Business WireMirna Therapeutics Reports First Quarter 2016 Financial Results and Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
27/04/201622h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MIRNSynlogic Com USD0.001
27/04/201622h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MIRNSynlogic Com USD0.001
 Showing the most relevant articles for your search:NASDAQ:MIRN

Dernières Valeurs Consultées

ASX
NCMIOC
LSE
91LD
Haven Fd.7%bd32
LSE
97PB
Mortgage 1 'b'
NASDAQI
BJK
VanEck Vectors Gaming ETF
EU
BPIQ
BPCE Maturity dt 03jun2025
EU
BE0002453281
TMVW TMVW4.2%11DEC25
BIT
F16655
Vontobel Financial Produ...
TG
2M6
Medtronic
BOV
BOEI34R
Boeing
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés